Clearasil Stubborn Acne Control 5in1 One Minute Mask

Manufacturer
Reckitt Benckiser LLC
Effective date
2017-11-13
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:09:23

Label at a glance#

ProductClearasil Stubborn Acne Control 5in1 One Minute Mask
Active ingredientSalicylic Acid
Label structure11 sections

Dosage and administration

use up to three times a week for a deeper treatment. Wet face, apply on to damp skin. Leave on for one minute. Rinse off thoroughly with warm water. Gently pat dry. if bothersome dryness or peeling occurs, reduce the frequency of application

Storage and handling

keep tightly closed store in a cool, dry place

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 2%

Purpose

OTC - PURPOSE SECTION

Acne medication

Use

INDICATIONS & USAGE SECTION

for the treatment of acne

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

  • avoid contact with the eyes. If product gets into the eyes, rinse thoroughly with water.
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • limit use to the face and neck

OTC - STOP USE SECTION

Stop use and ask a doctor if skin or eye irritation develops

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • use up to three times a week for a deeper treatment. Wet face, apply on to damp skin. Leave on for one minute. Rinse off thoroughly with warm water. Gently pat dry.
  • if bothersome dryness or peeling occurs, reduce the frequency of application

Other information

STORAGE AND HANDLING SECTION

  • keep tightly closed
  • store in a cool, dry place

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Kaolin, Bentonite, Glycerin, Sodium Laureth Sulfate, Titanium Dioxide, Niacinamide, Sodium Lactate, Xanthan Gum, Sodium Hydroxide, Cocamidopropyl Betaine, Coco-Glucoside, Hexyldecanol, Fragrance, Dipotassium Glycyrrhizate, Disodium EDTA, Bisabolol, Cetylhydroxyproline Palmitamide, Stearic Acid, Brassica Campestris (Rapeseed) Sterols, FD&C Blue No. 1, FD&C Yellow No. 6

Questions?

OTC - QUESTIONS SECTION

1-866-25-CLEAR (1-866-252-5327).
You may also report side effects to this phone number.

SPL UNCLASSIFIED SECTION

Distributed by:
Reckitt Benckiser
Parsippany, NJ 07054-0224
Made in USA

PRINCIPAL DISPLAY PANEL - 200 mL Tube Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Clearasil®

STUBBORN ACNE CONTROL
5IN1 ONE MINUTE MASK

Salicylic Acid Acne Medication

FIGHTS
5

STUBBORN
ACNE
PROBLEMS

FIGHTS 1. BLOCKED PORES 2. PIMPLE SIZE
3. EXCESS OIL 4. ACNE MARKS 5. BLACKHEADS

6.78 fl oz (200 mL)

PRINCIPAL DISPLAY PANEL - 200 mL Tube Label
PRINCIPAL DISPLAY PANEL - 200 mL Tube Label

FDA-Initiated Inactive NDC Indexing#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 23 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63824-44063824-440-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
fceac2a6-90ef-0172-e053-6294a90a0b2425958d29-b945-4e77-87b9-0a3796aa0db32023-05-30WarningsExact identifier
spl set id: 25958d29-b945-4e77-87b9-0a3796aa0db3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.